Neutra Corp NTRR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $583,579.82
- Volume/Avg
- 5.4 Mil / 5.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 33.33
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Neutra Corp is a development-stage company, which intends to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body's vital ability to heal and maintain itself. It focuses on the areas of anti-aging, sleep disorders, pain management, and others. Geographically, all the activities are operated through the region of the United States.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 15
- Website
- https://www.neutrainc.com
Valuation
|
Metric
|
NTRR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 33.33 |
Price/Cash Flow | — |
Price/Earnings
NTRR
Financial Strength
|
Metric
|
NTRR
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.02 |
Interest Coverage | −25.06 |
Quick Ratio
NTRR
Profitability
|
Metric
|
NTRR
|
|---|---|
Return on Assets (Normalized) | −813.79% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
NTRR
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Zmnjnhxfq | Bfbkr | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Trzgqkfl | Pzcqb | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Qrvjdyvk | Pwbbq | $97.8 Bil | |
MRNA
| Moderna Inc | Jrllsdnm | Kvfm | $41.3 Bil | |
ARGX
| argenx SE ADR | Kfpckgk | Trn | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Snzmlyj | Xfcp | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Xjvhwxpk | Hyxlc | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Mwdrzjkd | Rkwtww | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Pvhxmqpq | Qjyrd | $12.5 Bil | |
INCY
| Incyte Corp | Ylfkldsz | Mwhvsb | $11.6 Bil |